IL-28B genetic analysis and HBV disease association studies with small number study subjects; should we rely on results?

Muhammad Sohail Afzal

Abstract


NA

Keywords


IL-28B; HBV; Ethnicity

References


Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009;41:1105-1109.

Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, Dev A, Bell S, Pianko S, Chen R, Visvanathan K, Hammond R, Iser D, Rusli F, Sievert W, Desmond PV, Bowden DS, Thompson AJ. IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-a. Journal of Gastroenterology and Hepatology 28 (2013) 861–866

Lampertico P, Viganò M, Cheroni C, Facchetti F, Invernizzi F, Valveri V, Soffredini R, Abrignani S, De Francesco R, Colombo M. IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B. Hepatology. 2013 Mar;57(3):890-6. doi: 10.1002/hep.25749

Lee I-C, Lin C-H, Huang Y-H, Huo T-I, Su C-W, Hou MC, Huang HC, Lee KC, Chan CC, Lin MW, Lin HC, Lee SD. (2013) IL28B Polymorphism Correlates with Active Hepatitis in Patients with HBeAg-Negative Chronic Hepatitis B. PLoS ONE 8(2): e58071. doi:10.1371/journal.pone.0058071

Seto Wk, Wong DK, Kopaniszen M, Proitsi P, Sham P, Hung IF, Fung J, Lai C, Yuen M. HLA-DP and IL28B Polymorphisms: Influence of Host Genome on Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B. Clin Infect Dis. (2013) doi: 10.1093/cid/cit121

Chen J, Wang L, Li Y, Cai B, Fu Y, Liao Y, Zhang J. Association Analysis between SNPs in IL-28B Gene and the Progress of Hepatitis B Infection in Han Chinese. PLoS ONE 2012, 7(12): e50787. doi:10.1371/journal.pone.0050787

Li Y, Shi Y, Chen J, Cai B, Ying B, Wang L. Association of polymorphisms in interleukin-18 and interleukin-28B with hepatitis B recurrence after liver transplantation in Chinese Han population. Int J Immunogenet. 2012 Aug;39(4):346-52. doi: 10.1111/j.1744-313X.2012.01097.x

Ren S, Lu J, Du X, Huang Y, Ma L, Huo H, Chen X, Wei L. Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma. Cancer Immunol Immunother. 2012 Sep;61(9):1433-9. doi: 10.1007/s00262-012-1203-y

Martín-Carbonero L, Rallón NI, Benito JM, Poveda E, González-Lahoz J, Soriano V. Short communication: Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B? AIDS Res Hum Retroviruses. 2012 Oct;28(10):1262-4.

Lin CL, Tseng TC, Su TH, Liu CJ, Chen PJ, Lai MY, Chen DS, Kao JH. Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission. Hepatology International June 2012, Volume 6, Issue 3, pp 598-605

Wu X, Xin Z, Zhu X, Pan L, Li Z, Li H, Liu Y. Evaluation of susceptibility locus for response to interferon-α based therapy in chronic hepatitis B patients in Chinese. Antiviral Res. 2012 Feb;93(2):297-300. doi: 10.1016/j.antiviral.2011.12.009

Peng, L. J., Guo, J. S., Zhang, Z., Shi, H., Wang, J. and Wang, J. Y. (2012), IL28B rs12979860 polymorphism does not influence outcomes of hepatitis B virus infection. Tissue Antigens, 79: 302–305. doi: 10.1111/j.1399-0039.2011.01835.x

Sonneveld MJ, Wong VW, Woltman AM, Wong GL, Cakaloglu Y,Zeuzem S, Buster EH, Uitterlinden AG, Hansen BE, Chan HL, Janssen HL. Polymorphisms near IL28B and serological response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenterology 2012;142:513-52

de Niet A, Takkenberg RB, Benayed R, Riley-Gillis B,Weegink CJ, Zaaijer HL, et al. Genetic variation in IL28B and treatment outcome in HBeAgpositive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir. Scand J Gastroenterol 2012;47:475-481

Li W, Jiang Y, Jin Q, Shi X, Jin J, Gao Y, Pan Y, Zhang H, Jiang J, Niu J. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int. 2011 Sep; 31(8):1118-26. doi: 10.1111/j.1478-3231.2011.02507.x

Tseng TC, Yu ML, Liu CJ, Lin CL, Huang YW, Hsu CS, Liu CH, Kuo SF, Pan CJ, Yang SS, Su CW, Chen PJ, Chen DS, Kao JH. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-a-2a therapy. Antivir Ther 2011;16:629-637.

Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, Cmet S, Fornasiere E, Fumolo E, Fangazio S, Cerutti A, Minisini R, Pirisi M, Toniutto P. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. J Hepatol. 2011 Apr;54(4):716-22. doi:

1016/j.jhep.2010.07.019.

Jiao XL, Gao YT, Jing L, Liu T, Shi WX, Guo H, Yang B, DU Z. Studies on the relationship between polymorphism of IL-28B rs8099917 and the outcome of HBV infection. Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Nov;32(11):1143-7.


Full Text: PDF HTML

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.